3.0
May 3, 2026
Current employee, more than 1 year
San Francisco, CA
Recommend
CEO approval
Business Outlook
Pros
Big pharma with multiple sites around the world that one can leverage standardized SOPs and workflows.
Cons
Bureaucracy tends to slow down progress, very slow approval systems, quick to shutdown sites with short-term vision. Much lower salaries that other pharma companies in the Bay area.